FR314F - - Google Patents

Info

Publication number
FR314F
FR314F FR144905A FR144905A FR314F FR 314 F FR314 F FR 314F FR 144905 A FR144905 A FR 144905A FR 144905 A FR144905 A FR 144905A FR 314 F FR314 F FR 314F
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR144905A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR144905A priority Critical patent/FR314F/fr
Priority to BE729914D priority patent/BE729914A/xx
Priority to GB1380069A priority patent/GB1196229A/en
Priority to DE19691914456 priority patent/DE1914456A1/de
Application granted granted Critical
Publication of FR314F publication Critical patent/FR314F/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR144905A 1968-03-22 1968-03-22 Expired FR314F (xx)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR144905A FR314F (xx) 1968-03-22 1968-03-22
BE729914D BE729914A (xx) 1968-03-22 1969-03-14
GB1380069A GB1196229A (en) 1968-03-22 1969-03-17 Improvements in or relating to a New Glyoxylic Acid Salt, process for its preparation and Therapeutical Composition containing same
DE19691914456 DE1914456A1 (de) 1968-03-22 1969-03-21 Papaveringlyoxylat,seine Herstellung und Verwendung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR144905A FR314F (xx) 1968-03-22 1968-03-22

Publications (1)

Publication Number Publication Date
FR314F true FR314F (xx) 1970-05-25

Family

ID=8647868

Family Applications (1)

Application Number Title Priority Date Filing Date
FR144905A Expired FR314F (xx) 1968-03-22 1968-03-22

Country Status (4)

Country Link
BE (1) BE729914A (xx)
DE (1) DE1914456A1 (xx)
FR (1) FR314F (xx)
GB (1) GB1196229A (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ578503A (en) 2003-06-17 2011-02-25 Arena Pharm Inc Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
EP2189448B1 (en) 2003-06-17 2014-01-29 Arena Pharmaceuticals, Inc. Processes for the Separation of 3-Benzazepine Racemates
CA2588941A1 (en) 2004-12-23 2006-07-06 Arena Pharmaceuticals, Inc. 5ht2c receptor modulator compositions and methods of use
CN101466684B (zh) 2006-04-03 2012-06-20 艾尼纳制药公司 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体
CA2670285A1 (en) 2006-12-05 2008-06-12 Arena Pharmaceuticals, Inc. Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
CN102015591B (zh) 2008-03-04 2014-01-29 艾尼纳制药公司 制备与5-ht2c激动剂(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2011153206A1 (en) 2010-06-02 2011-12-08 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
KR20140091458A (ko) 2010-09-01 2014-07-21 아레나 파마슈티칼스, 인크. 신장 손상을 갖는 개체에 대한 로카세린의 투여
CN103189359A (zh) 2010-09-01 2013-07-03 艾尼纳制药公司 5-ht2c激动剂的光学活性酸盐
AU2011296003B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Modified-release dosage forms of 5-HT2C agonist useful for weight management
KR20130101524A (ko) 2010-09-01 2013-09-13 아레나 파마슈티칼스, 인크. 5-ht2c 아고니스트의 비-흡습성 염
CA2886875A1 (en) 2012-10-09 2014-04-17 Arena Pharmaceuticals, Inc. Method of weight management

Also Published As

Publication number Publication date
GB1196229A (en) 1970-06-24
BE729914A (xx) 1969-09-15
DE1914456A1 (de) 1971-06-16

Similar Documents

Publication Publication Date Title
AU1946070A (xx)
AU428130B2 (xx)
AU2374870A (xx)
AU5184069A (xx)
AU6168869A (xx)
AU6171569A (xx)
AU429879B2 (xx)
AU416157B2 (xx)
AU2581067A (xx)
AU4811568A (xx)
AU421558B1 (xx)
AU4744468A (xx)
AR203075Q (xx)
AU3789668A (xx)
AU3224368A (xx)
AU2580267A (xx)
AU479393A (xx)
BE708888A (xx)
AU463027A (xx)
AU4503667A (xx)
BE708951A (xx)
AU479894A (xx)
AU4464266A (xx)
AU4270368A (xx)
AU4224469A (xx)